We are live on
!
Find out more
MG
Marex Group Portfolio holdings
AUM
$15.8B
1-Year Est. Return
31.44%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.87B
AUM Growth
+$1.49B
(+34%)
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
17.74%
Top 10 Holdings %
Top 10 Hldgs %
45.81%
Holding
854
New
240
Increased
190
Reduced
182
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$272M |
| 2 |
Super Micro Computer
SMCI
|
+$243M |
| 3 |
NVIDIA
NVDA
|
+$159M |
| 4 |
Stryker
SYK
|
+$157M |
| 5 |
Advanced Micro Devices
AMD
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$176M |
| 2 |
Costco
COST
|
+$104M |
| 3 |
Linde
LIN
|
+$90.8M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$72.6M |
| 5 |
Blackrock
BLK
|
+$69.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.26% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Healthcare | 12.15% |
| 4 | Financials | 6.53% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Invesco Municipal Income Opportunities Trust
OIA
$296M
| $77.8K | ﹤0.01% |
+13,181
| New | +$86.1K |
|
627
Amylyx Pharmaceuticals
AMLX
$1.96B
| $75.6K | ﹤0.01% |
20,000
-20,000
| -50% | -$94.1K |
|
628
Polestar Automotive Holding UK
PSNY
$2.18B
| $74.6K | ﹤0.01% |
2,368
+38
| +2% | +$1.38K |
|
|
USGOW
629
DELISTED
U.S. GoldMining Inc Warrant
USGOW
| $74.1K | ﹤0.01% |
40,938
-23,190
| -36% | -$37.4K |
|
630
Fortuna Silver Mines
FSM
$2.55B
| $70.4K | ﹤0.01% |
+16,408
| New | +$78.3K |
|
|
YCBD.PRA
631
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
| $64.6K | ﹤0.01% |
87,333
+32,732
| +60% | +$23.1K |
|
632
Palisade Bio
PALI
$351M
| $59K | ﹤0.01% |
35,759
| – | – |
|
633
Gevo
GEVO
$445M
| $58.5K | ﹤0.01% |
28,000
-7,113
| -20% | -$13.5K |
|
634
ChargePoint
CHPT
$140M
| $58.4K | ﹤0.01% |
2,728
-7,115
| -72% | -$176K |
|
635
Acumen Pharmaceuticals
ABOS
$157M
| $57.3K | ﹤0.01% |
+33,300
| New | +$80.2K |
|
636
Metagenomi Therapeutics
MGX
$45.9M
| $54.1K | ﹤0.01% |
+15,000
| New | +$36.2K |
|
637
Microvast
MVST
$287M
| $51.5K | ﹤0.01% |
24,900
-35,294
| -59% | -$26.1K |
|
638
Rekor Systems
REKR
$83.1M
| $50.9K | ﹤0.01% |
+32,645
| New | +$33.9K |
|
|
ECDA
639
DELISTED
ECD Automotive Design
ECDA
| $50.4K | ﹤0.01% |
263
| – | – |
|
|
VIVO
640
VivoPower PLC
VIVO
$120M
| $49.6K | ﹤0.01% |
37,265
-48,430
| -57% | -$49.2K |
|
641
Lucid Motors
LCID
$2.52B
| $49.3K | ﹤0.01% |
1,633
-144
| -8% | -$3.75K |
|
642
AMC Entertainment Holdings
AMC
$2.04B
| $45.5K | ﹤0.01% |
+11,420
| New | +$50.1K |
|
|
IOBT
643
DELISTED
IO Biotech
IOBT
| $41.4K | ﹤0.01% |
45,000
| – | – |
|
644
Citizens
CIA
$249M
| $41.2K | ﹤0.01% |
+10,278
| New | +$46.2K |
|
|
HUYA
645
Huya Inc
HUYA
$551M
| $40.3K | ﹤0.01% |
13,128
-34,208
| -72% | -$121K |
|
|
BRAG
646
Bragg Gaming Group
BRAG
$42.5M
| $37K | ﹤0.01% |
+10,000
| New | +$40.8K |
|
647
Aclaris Therapeutics
ACRS
$765M
| $35.7K | ﹤0.01% |
14,400
| – | – |
|
|
MREO
648
Mereo BioPharma
MREO
$46.4M
| $35K | ﹤0.01% |
+10,000
| New | +$39.3K |
|
649
iQIYI
IQ
$1.17B
| $30.5K | ﹤0.01% |
15,192
-29,806
| -66% | -$70.6K |
|
|
AUTL
650
Autolus Therapeutics
AUTL
$405M
| $29.4K | ﹤0.01% |
12,500
-3,000
| -19% | -$10.1K |
|
Similar funds
CLGM
LCIP
EF
OAC
EH
NMO
Marex Group's Q4 2024 Portfolio in Review
As of Q4 2024, Marex Group held 854 positions worth $5.87B, up 34% from $4.38B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Marex Group deployed $1.04B of net new capital in Q4 2024, opening 240 new positions and adding to 190 existing holdings. Its largest new stake was Hilton Worldwide: 225,008 shares worth $55.6M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Strategy Inc, an estimated $176M trimmed.
- Marex Group's largest Q4 2024 buy was Hilton Worldwide: 225,008 shares worth $55.6M.
- Marex Group added most to Tesla in Q4 2024, an estimated $272M increase.
- Marex Group's biggest Q4 2024 reduction was Strategy Inc, cutting an estimated $176M.
- Marex Group fully exited Cigna in Q4 2024, selling an estimated $34.7M.
- Marex Group's ten largest holdings make up 46% of its $5.87B portfolio in Q4 2024.
- Marex Group opened 240 new positions and closed 177 in Q4 2024.
- Marex Group's portfolio value rose 34% quarter-over-quarter to $5.87B.
Based on Marex Group's 13F filing for Q4 2024, filed 2 Apr 2026.